Technical success rate of EUS-guided radio-frequency ablation for hepatocellular carcinoma versus percutaneous ablation

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180919002

Enrollment

Registered

2018-09-19

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with liver mass diagnoses with hepatocellular carcinoma

Interventions

Use of RFA via EUS for hepatocellular carcinoma,use of RFA delivered percutaneously for hepatocellular carcinoma

Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery

EUS guided RFa for hepatocellular carcinoma,Percutaneous guided RFA for hepatocellular carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 80 years old Non-vascular, non-necrotic, EUS-approachable SOLID LIVER MASS without massive ascites Biochemical and radiological evidence of non-cirrhotic

Exclusion criteria

Exclusion criteria: Pregnancy Blood dyscrasia /Anti-thrombotics less than 1 week / INR: >1.5

Design outcomes

Primary

Measure	Time frame
Success rate of EUS guided RFA versus percutaneous RFA for hepatocellular carcinoma 3 months size of lesion	—

Secondary

Measure	Time frame
Safety of eus guided rfa versus percutaneous 1 week number of complications	—

Countries

Thailand

Contacts

Public ContactPradermchai Kongkam

King Chulalongkorn Memorial Hospital

kongkam@hotmail.com0805575111

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Technical success rate of EUS&#45;guided radio&#45;frequency ablation for hepatocellular carcinoma versus percutaneous ablation